Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation to Reveal the Immune Reaction Upon COVID-19 Vaccination in the Belgian Cancer Population: COVID-19 Protection and Vaccine Safety (REAL-V)

NCT05033158 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT05033158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05033158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation to Reveal the Immune Reaction Upon COVID-19 Vaccination in the Belgian Cancer Population: COVID-19 Protection and Vaccine Safety (REAL-V)
Lead sponsor
University Hospital, Antwerp
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2021
Completion date
June 13, 2023
Enrollment
402 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

cancer